rosiglitazone has been researched along with gw9662 in 137 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 56 (40.88) | 29.6817 |
2010's | 70 (51.09) | 24.3611 |
2020's | 11 (8.03) | 2.80 |
Authors | Studies |
---|---|
Chen, WM; Huang, MY; Lin, J; Sun, JR; Sun, PH; Wang, F; Wang, HY | 1 |
Chang, YQ; Chen, WM; Lin, J; Liu, J; Sun, PH; Wang, F; Xu, XJ; Zeng, T | 1 |
Cai, S; Cichewicz, RH; Doench, JG; Grant, CV; Liang, H; Mooberry, SL; O'Keefe, BR; Risinger, AL | 1 |
Brunsveld, L; de Vries, RMJM; Leijten-van de Gevel, IA; Ottenheym, NJ; Ottmann, C; van Herk, KHN | 1 |
Auwerx, J; Capron, M; Dombrowicz, D; Honda, K; Loyens, M; Papin, JP; Staels, B; Woerly, G | 1 |
Angeli, V; de Heer, HJ; Hammad, H; Hoogsteden, HC; Lambrecht, BN; Soullié, T; Trottein, F | 1 |
Baker, DL; Balazs, L; Bittman, R; Byun, HS; Johnson, LR; Makarova, N; Marathe, GK; McIntyre, TM; Prestwich, GD; Tigyi, G; Xu, Y; Yasuda, S; Zhang, C | 1 |
Fritsche, KL; Zhang, M | 1 |
Benéteau, N; Chapuis, V; Colpaert, FC; Dupont-Passelaigue, E; Junquéro, D; Lestienne, F; Patoiseau, JF; Rival, Y; Taillandier, T | 1 |
Alegret, M; Ciudad, CJ; Laguna, JC; Llaverias, G; Noé, V; Sánchez, RM; Vázquez-Carrera, M | 1 |
Gill, JH; Seargent, JM; Yates, EA | 1 |
Chen, J; Chen, Q; Jiang, H; Shen, J; Shen, X; Sun, T | 1 |
Camacho, IE; De Strooper, B; Dominguez, D; Merchiers, P; Serneels, L; Spittaels, K | 1 |
Burgess, HA; Daugherty, LE; Lakatos, HF; Phipps, RP; Ray, DM; Redonnet, M; Sime, PJ; Thatcher, TH | 1 |
Borkan, SC; Matsuhashi, N; Nakajima, A; Ohnishi, S; Saubermann, LJ; Schaefer, KL; Takahashi, H; Turner, JR; Wada, K; Wolfe, MM | 1 |
Han, KH; Hong, KH; Kim, JB; Kim, JJ; Ko, J; Pak, YK; Park, SW; Ryu, J | 1 |
Allred, CD; Kilgore, MW | 1 |
Betz, MJ; Beuschlein, F; Fassnacht, M; Hahner, S; Reincke, M; Shapiro, I | 1 |
Hart, CM; Mazzella, LJ; Polikandriotis, JA; Rupnow, HL | 1 |
Balaguer, P; Carlavan, I; Lemaire, G; Nicolas, JC; Perrin, A; Pillon, A; Seimandi, M; Vignon, F; Voegel, JJ | 1 |
Benko, I; Djazayeri, K; Kiss, A; Nagy, L; Németh, J; Peitl, B; Szabó, B; Szilvássy, Z | 1 |
Geng, ZL; Liu, D; Wang, YL; Zeng, BX; Zeng, L; Zhang, SF; Zhang, SH | 1 |
Liu, D; Yao, SL; Zeng, BX; Zhang, SH | 1 |
Campbell, SC; Macfarlane, WM; Richardson, H; Smith, SA | 1 |
Brunskill, NJ; Chana, RS | 1 |
Chen, J; Graham, SH; Hong, Z; Luo, Y; Signore, AP; Wang, S; Yin, W; Zhang, F | 1 |
Patel, S; Rehan, VK; Santos, J; Torday, JS; Wang, Y | 1 |
Kurosaki, E; Maruyama, T; Nakano, R; Shibasaki, M; Shimaya, A; Yokono, M; Yoshida, S | 1 |
Jang, KY; Jang, YB; Kang, KP; Kim, DH; Kim, W; Lee, JE; Lee, S; Moon, SO; Park, SK; Sung, MJ | 1 |
Jin, SM; Kim, SR; Kim, UH; Lee, KS; Lee, MK; Lee, YC; Min, KH; Park, HS; Park, SJ | 1 |
Coales, SJ; Griffin, PR; Hamuro, Y; Molnar, KS; Morrow, JA; Southern, MR; Tuske, SJ | 1 |
Chen, K; Ding, H; Jiang, H; Luo, H; Shen, X; Sun, T; Ye, F | 1 |
Bowen, KK; Feinstein, DL; Kapadia, R; Liang, J; Satriotomo, I; Tureyen, K; Vemuganti, R | 1 |
Authier, H; Auwerx, J; Balard, P; Benoit-Vical, F; Berry, A; Chambon, P; Coste, A; Desvergne, B; Lagane, C; Lepert, JC; Magnaval, JF; Metzger, D; Olagnier, D; Pipy, B; Séguéla, JP; Wahli, W | 1 |
Cao, JG; Dong, L; Liu, HQ; Qin, Y; Sun, L; Tang, XQ; Xia, H; Zhang, YQ | 1 |
Combs, CK; Woster, AP | 1 |
Baek, HA; Choi, HN; Chung, MJ; Jang, KY; Kim, KR; Lee, HJ; Moon, WS; Park, HS | 1 |
Flier, JS; Gardner, NP; Guan, HP; Kershaw, EE; Lazar, MA; Schupp, M | 1 |
Hong, SH; Hwang, YC; Kim, HS; Kim, KW; Lee, MK; Lee, MS; Noh, JH; Yang, TY | 1 |
Allred, CD; Kilgore, MW; Southard, RC; Talbert, DR; Wang, X | 1 |
Borenstein, X; Jasnis, MA; Magenta, G; Rolando, R | 1 |
Hong, KW; Kim, CD; Kim, EK; Kim, KY; Lee, JH; Lee, WS; Park, SY; Yun, SJ | 1 |
Egea, J; García, AG; López, MG; Martínez, A; Rosa, AO | 1 |
Bai, L; Liu, ML; Miao, F; Pei, HH; Qiao, WH | 1 |
Bai, MH; Liu, XX; Ma, HB; Wang, XJ; Xue, FJ; Xue, XH | 1 |
Bronfman, M; Fuenzalida, K; Jin, YN; Johnson, GVW; Quintanilla, RA | 1 |
Brooks, N; Lang, BT; Park, SW; Vemuganti, R; Yi, JH | 1 |
Chen, FL; Hu, RM; Li, LX; Liang, WC; Liu, Y; Wang, XC; Yang, YH; Yang, ZH; Zhou, WB | 1 |
Gidlund, M; Jancar, S; Ketelhuth, DF; Melo, IB; Rios, FJ | 1 |
Hammond, GL; Selva, DM | 1 |
Lin, TN; Wu, JS; Wu, KK | 1 |
Jeon, JG; Jhee, EC; Kim, JH; Lee, JC; Lee, YH; Yi, HK; Yu, MK | 1 |
Bonnans, C; Chanez, P; Godard, P; Gras, D; Urbach, V; Vachier, I | 1 |
Chan, LY; Lai, KN; Leung, JC; Tang, SC; Xiao, J | 1 |
Houtman, R; Jeninga, EH; Kalkhoven, E; Koppen, A; Pijnenburg, D; Ruijtenbeek, R | 1 |
De Backer, O; Elinck, E; Lefebvre, RA; Leybaert, L; Priem, E | 1 |
Bennett, RG; Singh, S | 1 |
Al-Rasheed, NM; Eissa Ahmed, AA | 1 |
Karpushev, AV; Levchenko, V; Pavlov, TS; Staruschenko, A; Vandewalle, A | 1 |
Chen, Y; Li, Y; Sun, C; Wang, Y; Wen, Y | 1 |
Cheng, Y; Liang, H; Sun, GM; Sun, L; Xu, YW | 1 |
Abdel-Aleem, OS; Badr, MZ; Donahue, RR; McNamara, KC; Morgenweck, J; Taylor, BK | 1 |
Calmes, JM; Darimont, C; Gaillard, RC; Giusti, V; Leyvraz, C; Paroz, A; Pralong, FP; Suter, M; Verdumo, C | 1 |
Clerget-Froidevaux, MS; Decherf, S; Demeneix, B; Elgaaied, AB; Guissouma, H; Kouidhi, S; Seugnet, I | 1 |
Lai, CC; Yang, CR | 1 |
Bi, F; Liu, JN; Su, Y; Tang, Y; Zhang, J | 1 |
Chen, J; Chen, Q; Cheng, L; Sun, X; Sun, Z; Wang, J; Wang, Y | 1 |
Carluccio, MA; De Caterina, R; Distante, A; Massaro, M; Scoditti, E; Storelli, C | 1 |
Atherton, RE; Gibbins, JM; Jones, CI; Kaiser, WJ; Moraes, LA; Sage, T; Spyridon, M | 1 |
Cheng, HL; Shi, JX; Wu, Y; Xue, YJ; Yin, HX; Zhao, XD; Zhuang, Z | 1 |
Hu, Z; Lin, Y; Perez-Polo, JR; Ye, Y; Zhang, C | 1 |
Brayman, MJ; Carson, DD; Dharmaraj, N; Wang, P | 1 |
Banerjee, A; Flynt, L; Ghosh, S; Mellema, M; Panettieri, RA; Shore, SA; Williams, E; Zhu, M | 1 |
Han, F; Kong, LB; Nan, YM; Wang, RQ; Wu, WJ; Yu, J; Zhao, SX | 1 |
Armani, C; Bardelli, C; Breschi, MC; Brunelleschi, S; Carmazzi, Y; Celi, A; Cordazzo, C; Neri, T; Paggiaro, P; Pegoli, A | 1 |
Park, SY; Sohn, UD | 1 |
Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Massi, M; Ruggeri, B; Somaini, L; Stopponi, S | 1 |
Dai, SS; Fu, XH; He, FT; Li, GB; Li, J; Wu, GZ; Zeng, YJ; Zhong, D | 1 |
Blumberg, B; Li, X; Ycaza, J | 1 |
Chen, C; Chen, X; Du, H; Zhang, J | 1 |
Li, J; Morrison, A; Tong, C; Yan, X | 1 |
Chen, H; Chen, N; Han, L; Lu, Y; Wang, WM; Zhong, F | 1 |
Badinga, L; Perdomo, MC; Santos, JE | 1 |
Dai, XJ; Fang, ZG; Huang, HQ; Huang, RW; Lin, DJ; Liu, JJ; Liu, PQ; Liu, XD; Xiao, RZ; Xu, Y; Zhang, Y | 1 |
El-Bouchtaoui, M; Gomez, D; Ho-Tin-Noé, B; Le Dall, J; Legrès, L; Louedec, L; Meilhac, O; Michel, JB; Vranckx, R | 1 |
Baharvand, H; Esmaeili, A; Ghaedi, K; Ghoochani, A; Hashemi, M; Karamali, F; Karbalaei, K; Nasr-Esfahani, MH; Peymani, M; Salamian, A; Shabani, K; Tanhaie, S; Valian-Borujeni, S | 1 |
Hwang, WY; Jin, YN; Jo, C; Johnson, GV | 1 |
Martin, HL; Mounsey, RB; Mustafa, S; Sathe, K; Teismann, P | 1 |
Bingham, V; Campbell, FC; Deevi, RK; Fatehullah, A; Jagan, I | 1 |
Chen, T; Cheng, H; Crawford, BH; Ding, G; Jin, X; Saafir, TB; Wagner, MB; Yuan, Z | 1 |
Bucolo, C; Drago, F; Salomone, S; Siarkos, I; Sinagra, T; Tamburella, A; Urso, V | 1 |
Czernik, PJ; Lecka-Czernik, B; Lu, Y; Rahman, S | 1 |
Cai, Y; Chang, JR; Guan, YF; Jia, MZ; Peng, DQ; Qi, YF; Tang, CS; Wu, W; Yu, YR; Zhang, J; Zhou, YB | 1 |
Albertz, J; Duan, W; Guo, Z; Jin, J; Peng, Q; Ross, CA; Rudow, G; Troncoso, JC | 1 |
Auclair, M; Boccara, F; Capeau, J; Capel, E; Caron-Debarle, M; Guerci, B; Lascols, O; Vigeral, C; Vigouroux, C | 1 |
Anwyl, R; Bao, X; Li, S; Liu, G; Wang, Q; Wu, J; Xu, S; Zheng, B | 1 |
Bogacka, I; Bogacki, M; Chojnowska, K; Kurzyńska, A | 2 |
Balschi, JA; Duan, SZ; He, H; McGowan, FX; Mortensen, RM; Tao, H; Xiong, H | 1 |
Emoto, M; Fukumoto, S; Imanishi, Y; Inaba, M; Ishimura, E; Koyama, H; Mori, K; Morioka, T; Motoyama, K; Nakatani, S; Ochi, A | 1 |
Denner, L; Dineley, KT; Hernandez, CM; Jahrling, JB | 1 |
Balvers, MG; Dwarkasing, J; Lute, C; Meijerink, J; Plastina, P; Poland, M; van Norren, K; Witkamp, RF | 1 |
Casali, CI; Faggionato, D; Gómez, EM; Tome, MC; Weber, K | 1 |
Aires, V; Brassart, B; Carlier, A; Delmas, D; Limagne, E; Mandard, S; Martiny, L; Scagliarini, A; Solary, E; Tarpin, M | 1 |
Drwal, E; Rak-Mardyła, A | 1 |
You, S; Zhou, X | 1 |
Diano, S; Horvath, TL; Jeong, JK; Long, L; Toda, C | 1 |
Bakhtiyari, S; Gerayesh-Nejad, S; Meshkani, R; Sadeghi, A; Taheripak, G; Zarghooni, M | 1 |
Arango-Rodriguez, M; Conget, P; Contador, D; Espinosa, M; Ezquer, F; Puebla, C; Sobrevia, L | 1 |
Brüne, B; Ferreirós, N; Flesch, D; Giegerich, AK; Knape, T; Kuchler, L; Labocha, S; Parnham, MJ; Proschak, E; Schmid, T; Schubert-Zsilavecz, M; Sha, LK; von Knethen, A; Wurglics, M | 1 |
Bai, MM; Hao, F; Kuang, HY; Meng, P; Mu, JW; Yu, QX; Zhang, HJ | 1 |
Dong, X; Gao, D; Hao, G; Liu, Z; Meng, Z; Ning, N; Niu, X; Yang, G | 1 |
Baharvand, H; Ghaedi, K; Hashemi, MS; Kalantar, SM; Nasr-Esfahani, MH; Peymani, M; Zadegan, FG | 1 |
Dai, L; Sun, Y; Wang, J; Yu, L | 2 |
Hu, J; Jing, X; Li, W; Su, P; Wang, X; Wu, X; Zhang, H; Zhang, X; Zhou, G | 1 |
Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
Cho, DH; Jo, I; Kim, SA; Park, JH; Park, JY; Seo, J; Song, KH | 1 |
Araújo, CV; Bozza, PT; Campbell, C; Castro-Faria-Neto, HC; Cody, MJ; Gonçalves-de-Albuquerque, CF; Molinaro, R; Silva, AR; Weyrich, AS; Yost, CC; Zimmerman, GA | 1 |
Cheng, SJ; Hung, WC; Lee, WT; Min, MY; Wong, SB | 1 |
Carson, DD; Morgado, M | 1 |
Ko, J; Koh, HC; Park, JH; Park, YS | 1 |
Agarwal, AK; Garg, A; Sankella, S | 1 |
Cui, X; Hong, L; Jin, HH; Li, X; Liu, LP; Liu, X; Zhang, B; Zhang, QG | 1 |
Adeyi, OA; Echeverri, J; Farrokhi, K; Ganesh, S; Hamar, M; Kaths, JM; Kollmann, D; Linares, I; Selzner, M; Selzner, N; Urbanellis, P; Yip, P | 1 |
Assfalg, V; Cheng, Z; Friess, H; Hartmann, D; Hüser, N; Kleeff, J; Laschinger, M; Liu, L; Lu, M; Michalski, CW; Sunami, Y; von Figura, G; Wang, Y; Zhang, XJ | 1 |
Chen, ZA; Huang, TT; Li, PY; Li, Y; Lu, BW; Wen, DX; Xuan, W; Yu, WF; Zhang, YM; Zhou, NY; Zhu, ZY | 1 |
Blayo, AL; Chrisman, IM; Diaz, P; Griffin, PR; Heidari, Z; Hughes, TS; Kamenecka, TM; Mendes, DE; Nemetchek, MD; Novick, SJ; Patton, T | 1 |
Li, Q; Rao, J; Yang, C; Yang, H; Zhang, W; Zhang, X | 1 |
Chang, EM; Jang, H; Kim, R; Lee, DR; Lee, JI; Lee, WS; Seol, D; Shin, DH; Yoon, SY | 1 |
Blitek, A; Szymanska, M | 1 |
Chen, J; Cui, X; Liu, L; Qiao, N; Yang, J; Zhang, X; Zhang, Y | 1 |
Chen, G; Dong, YH; Du, ZY; Hu, J; Sun, YR; Tan, B; Wei, C; Xiao, X; Xie, R; Yu, J; Yuan, Q; Zhao, JL | 1 |
Astakhova, AA; Chistyakov, DV; Goriainov, SV; Sergeeva, MG | 1 |
Luo, X; Wu, G; Wu, J | 1 |
Jiamei, L; Jianhua, S; Liang, Y | 1 |
Jiao, Y; Ren, S; Wang, L; Wu, G | 1 |
137 other study(ies) available for rosiglitazone and gw9662
Article | Year |
---|---|
Design, synthesis and anti-inflammatory evaluation of novel 5-benzylidene-3,4-dihalo-furan-2-one derivatives.
Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylidene Compounds; Cell Line; Cell Survival; Drug Design; Furans; Interleukin-6; Mice; Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Structure; NF-kappa B; Nitric Oxide; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2014 |
4-arylamidobenzyl substituted 5-bromomethylene-2(5H)-furanones for chronic bacterial infection.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Humans; Lipopolysaccharides; Male; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide; PPAR gamma; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; RAW 264.7 Cells | 2018 |
CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Aldehyde Oxidoreductases; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; CRISPR-Cas Systems; Female; Gene Knockout Techniques; Humans; Molecular Structure; Neoplastic Stem Cells; PPAR gamma; RNA, Small Interfering; Triple Negative Breast Neoplasms | 2020 |
Indazole MRL-871 interacts with PPARγ via a binding mode that induces partial agonism.
Topics: Indazoles; Ligands; Nuclear Receptor Subfamily 1, Group F, Member 3; PPAR gamma; Protein Structure, Secondary | 2022 |
Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.
Topics: Anilides; Animals; Asthma; Chemotaxis; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Eosinophils; GATA3 Transcription Factor; Humans; Inflammation; Lung; Mice; Mice, Inbred BALB C; Mice, Knockout; Rats; Receptors, Cytoplasmic and Nuclear; Respiratory Hypersensitivity; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors | 2003 |
Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.
Topics: Anilides; Animals; Asthma; Cell Movement; Cytokines; Dendritic Cells; Disease Models, Animal; Eosinophils; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transcription Factors; Vasodilator Agents | 2004 |
Lysophosphatidic acid induces neointima formation through PPARgamma activation.
Topics: Analysis of Variance; Anilides; Animals; Arteriosclerosis; Calmodulin-Binding Proteins; Carotid Artery Diseases; CD36 Antigens; Cells, Cultured; Disease Models, Animal; DNA Primers; Growth Substances; Ligands; Lipoproteins, LDL; Lysophospholipids; Male; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Time Factors; Transcription Factors | 2004 |
Fatty acid-mediated inhibition of IL-12 production by murine macrophages is independent of PPARgamma.
Topics: Anilides; Animals; Arachidonic Acid; Cells, Cultured; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Female; Interleukin-12; Ligands; Linoleic Acid; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2004 |
Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
Topics: Acetamides; Acetates; Anilides; Cardiovascular Agents; Cell Line; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fenofibrate; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins, LDL; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mevalonic Acid; Monocytes; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tetradecanoylphorbol Acetate; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcription Factors | 2004 |
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.
Topics: Anilides; Animals; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspase 3; Caspases; Caveolin 1; Caveolins; CD11b Antigen; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Hydroxycholesterols; Ligands; Liver X Receptors; Macrophages; Molecular Sequence Data; Orphan Nuclear Receptors; PPAR gamma; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transcription, Genetic; Up-Regulation; Vasodilator Agents | 2004 |
GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.
Topics: Anilides; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Humans; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2004 |
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
Topics: alpha-Galactosidase; Anilides; Cells, Cultured; Chromans; CREB-Binding Protein; Drug Evaluation, Preclinical; Genes, Reporter; Indomethacin; Ligands; Nuclear Proteins; Oxazoles; Pioglitazone; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Trans-Activators; Troglitazone; Two-Hybrid System Techniques; Tyrosine; Yeasts | 2004 |
Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.
Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anilides; Animals; Aspartic Acid Endopeptidases; Cell Line; Cell Line, Tumor; Cells, Cultured; Cerebral Cortex; Chromans; Culture Media, Conditioned; Endopeptidases; Humans; Kidney; Mice; Neuroblastoma; Neuroglia; Neurons; Peptide Fragments; Pioglitazone; PPAR gamma; Protein Processing, Post-Translational; Receptor, Notch1; Receptors, Cell Surface; Recombinant Fusion Proteins; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone | 2004 |
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.
Topics: Actins; Anilides; Cell Differentiation; Collagen Type I; Fibroblasts; Humans; Hypoglycemic Agents; Lung; Muscle, Smooth; PPAR gamma; Prostaglandin D2; Pulmonary Fibrosis; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta | 2005 |
Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
Topics: Anilides; Anoikis; Benzamides; Carcinoma, Hepatocellular; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Shape; Chromans; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrin beta1; Liver Neoplasms; PPAR gamma; Protein-Tyrosine Kinases; Pyridines; Rosiglitazone; Thiazolidinediones; Troglitazone | 2005 |
HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Topics: Anilides; Animals; Aorta; Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Depression, Chemical; Diet, Atherogenic; Down-Regulation; Drug Evaluation, Preclinical; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Monocytes; Polyisoprenyl Phosphates; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Chemokine; RNA, Messenger; Rosiglitazone; Sesquiterpenes; Simvastatin; Thiazolidinediones | 2005 |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Topics: Alitretinoin; Anilides; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; HT29 Cells; Humans; Ligands; Lung Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection; Tretinoin | 2005 |
Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Anilides; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin E; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor II; Male; Middle Aged; PPAR gamma; Promoter Regions, Genetic; Receptor, Melanocortin, Type 2; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2005 |
Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
Topics: Anilides; Cells, Cultured; Endothelium, Vascular; Genes, Reporter; Humans; Hypoglycemic Agents; Ligands; Nitric Oxide; PPAR gamma; Prostaglandin D2; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Umbilical Veins | 2005 |
Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
Topics: Anilides; Benzhydryl Compounds; Butyrates; DNA-Binding Proteins; Epoxy Compounds; Genes, Reporter; HeLa Cells; Humans; Inhibitory Concentration 50; Ligands; Luciferases; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; PPAR alpha; PPAR delta; PPAR gamma; Rosiglitazone; Saccharomyces cerevisiae Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 2005 |
Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
Topics: Administration, Oral; Anilides; Animals; Antimetabolites, Antineoplastic; Blood Glucose; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Female; Fluorouracil; Granulocyte Precursor Cells; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Hypoglycemic Agents; Injections, Intraperitoneal; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Rosiglitazone; Thiazolidinediones; Time Factors | 2005 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
Topics: Anilides; Animals; Endotoxemia; Lipopolysaccharides; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Rats, Wistar; Respiratory Distress Syndrome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tyrosine | 2005 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Blotting, Western; Chemokine CXCL1; Chemokines, CXC; Endotoxemia; Immunohistochemistry; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophil Infiltration; NF-kappa B; Peroxidase; Pneumonia; PPAR gamma; Pulmonary Edema; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2005 |
Effects of rosiglitazone and metformin on pancreatic beta cell gene expression.
Topics: Active Transport, Cell Nucleus; Anilides; Animals; Cell Line; Cell Nucleus; DNA; Gene Expression; Glucose; Hepatocyte Nuclear Factor 3-beta; Homeodomain Proteins; Insulin-Secreting Cells; Metformin; Mice; Proinsulin; Promoter Regions, Genetic; Protein Binding; Rats; Rosiglitazone; Thiazolidinediones; Time Factors; Trans-Activators | 2006 |
Thiazolidinediones inhibit albumin uptake by proximal tubular cells through a mechanism independent of peroxisome proliferator activated receptor gamma.
Topics: Albumins; Anilides; Animals; Cells, Cultured; Cholesterol; Chromans; Farnesol; Kidney Tubules, Proximal; Ligands; Mevalonic Acid; Opossums; Polyisoprenyl Phosphates; PPAR gamma; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Troglitazone | 2006 |
Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Topics: Anilides; Animals; Animals, Newborn; Behavior, Animal; Blood Pressure; Body Temperature; Brain Ischemia; Cells, Cultured; Cerebral Infarction; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intercellular Adhesion Molecule-1; Interleukin-3; Lectins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Peroxidase; PPAR gamma; Psychomotor Performance; Recombinant Fusion Proteins; Recombinant Proteins; Reperfusion; Rosiglitazone; Thiazolidinediones | 2006 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.
Topics: Actins; Anilides; Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Female; Fibroblasts; Gene Expression; Hyperoxia; Lung; Lung Diseases; Lung Injury; Male; Membrane Proteins; Perilipin-2; PPAR gamma; Pregnancy; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein B; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2006 |
Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Anilides; Animals; Binding, Competitive; Body Weight; Dietary Carbohydrates; Dietary Fats; Disease Models, Animal; Glucose Tolerance Test; Hepatocytes; Male; Mice; Mice, Inbred C57BL; Obesity; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2006 |
Rosiglitazone ameliorates cisplatin-induced renal injury in mice.
Topics: Anilides; Animals; Apoptosis; C-Peptide; Cell Line; Chromans; Cisplatin; Drug Evaluation, Preclinical; Glioma; Humans; Hypoglycemic Agents; Inflammation; Insulin; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Inbred C57BL; Monocytes; PPAR gamma; Prostaglandin D2; Protein Transport; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA; Troglitazone; Tumor Necrosis Factor-alpha | 2006 |
Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice.
Topics: Anilides; Animals; Asthma; Chemokine CCL5; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; NF-kappa B; Pioglitazone; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Vascular Cell Adhesion Molecule-1 | 2006 |
Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
Topics: Amides; Amino Acid Sequence; Anilides; Benzophenones; Binding Sites; Deuterium Exchange Measurement; Indoles; Ligands; Mass Spectrometry; Models, Molecular; Pepsin A; Peptide Fragments; PPAR gamma; Protein Conformation; Protein Structure, Tertiary; Rosiglitazone; Sulfides; Thiazolidinediones; Tyrosine | 2006 |
Quantitative characterization of 15-deoxy-delta(12,14)-prostaglandin J2 in regulating EGFPSmad2 translocation in CHO cells through PPARgamma/TGFbeta/Smad2 pathway.
Topics: Anilides; Animals; Biological Transport; Blotting, Western; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Green Fluorescent Proteins; Microscopy, Fluorescence; Models, Biological; PPAR gamma; Prostaglandin D2; Recombinant Fusion Proteins; Rosiglitazone; Signal Transduction; Smad2 Protein; Thiazolidinediones; Transfection; Transforming Growth Factor beta | 2006 |
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Topics: Anilides; Animals; Cerebral Infarction; Chemotaxis, Leukocyte; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Encephalitis; Hypertension; Intercellular Adhesion Molecule-1; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroprotective Agents; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Superoxide Dismutase-1; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones | 2007 |
IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
Topics: Anilides; Animals; Arachidonic Acids; CD36 Antigens; Cell Line, Tumor; DNA; Enzyme Inhibitors; Erythrocytes; Gene Expression; Humans; Hypoglycemic Agents; Interleukin-13; Macrophages; Macrophages, Peritoneal; Mice; Monocytes; Organophosphonates; Phagocytosis; Phospholipases A; Phospholipases A2; Plasmodium falciparum; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Transfection | 2007 |
Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Topics: Anilides; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Fluorouracil; Gene Expression Regulation; Humans; Hypoglycemic Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones | 2007 |
Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Cytokines; Humans; I-kappa B Proteins; Ligands; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Microglia; Monocytes; NF-KappaB Inhibitor alpha; PPAR gamma; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones | 2007 |
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Topics: Anilides; Benzamides; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Chromans; Colony-Forming Units Assay; Humans; Hypoglycemic Agents; Immunoenzyme Techniques; Ligands; Liver Neoplasms; Neoplasm Invasiveness; PPAR gamma; Pyridines; Rosiglitazone; Thiazolidinediones; Troglitazone; Vimentin | 2007 |
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Anilides; Animals; Carboxylic Ester Hydrolases; Cycloheximide; Dietary Fats; Dose-Response Relationship, Drug; Fluorenes; Gene Expression; Leptin; Lipase; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; PPAR gamma; Prostaglandin D2; Protein Biosynthesis; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2007 |
Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression.
Topics: Anilides; Animals; Basic Helix-Loop-Helix Transcription Factors; Cells, Cultured; Glucokinase; Glucose; Glucose Transporter Type 2; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Insulinoma; Male; Nerve Tissue Proteins; PPAR gamma; Rats; Rats, Inbred OLETF; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2008 |
PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells.
Topics: Anilides; Cell Proliferation; Colonic Neoplasms; Eicosapentaenoic Acid; Gene Expression Regulation; HT29 Cells; Humans; Male; PPAR gamma; Prostatic Neoplasms; Protein Binding; Response Elements; Rosiglitazone; Thiazolidinediones | 2008 |
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Topics: Administration, Oral; Anilides; Animals; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2008 |
Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription.
Topics: 3T3-L1 Cells; Anilides; Animals; Cell Differentiation; Chlorocebus aethiops; Cilostazol; COS Cells; Fibroblasts; Glucose; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Mice; Phosphodiesterase Inhibitors; PPAR gamma; Rosiglitazone; Tetrazoles; Thiazolidinediones | 2008 |
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
Topics: Anilides; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Neuroprotective Agents; Organ Culture Techniques; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiadiazoles; Thiazolidinediones | 2008 |
[Effects of peroxisome proliferators-activated receptor-gamma on the function of the vital organs in rats with pancreatitis].
Topics: Anilides; Animals; Hypoglycemic Agents; Injections, Intravenous; Male; Multiple Organ Failure; NF-kappa B; Pancreatitis, Acute Necrotizing; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2008 |
[Effects of activated PPARgamma on the expression of PTEN gene in pancreatic cancer cells].
Topics: Anilides; Cell Line, Tumor; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Pancreatic Neoplasms; PPAR gamma; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2008 |
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.
Topics: Anilides; Animals; Corpus Striatum; Huntingtin Protein; Huntington Disease; Hypoglycemic Agents; Membrane Potentials; Mice; Mitochondria; Mutation; Nerve Tissue Proteins; Nuclear Proteins; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Signal Transduction; Thapsigargin; Thiazolidinediones | 2008 |
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Topics: Analysis of Variance; Anilides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blotting, Western; Brain Injuries; Cerebral Cortex; Gene Expression; HSP27 Heat-Shock Proteins; Hypoglycemic Agents; In Situ Nick-End Labeling; Injections, Intraperitoneal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2008 |
Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway.
Topics: Anilides; Atherosclerosis; Berberine; Cell Line; Chemokine CCL2; Humans; Hypoglycemic Agents; Interleukin-6; Lipoproteins, LDL; Macrophages; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2008 |
Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line.
Topics: Anilides; CD11b Antigen; CD18 Antigens; CD36 Antigens; Cell Differentiation; Cell Line; Chromatography, Ion Exchange; Fatty Acids, Unsaturated; Humans; Lipoproteins, LDL; Monocytes; Oxidation-Reduction; PPAR gamma; Receptors, IgG; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Thiobarbituric Acid Reactive Substances | 2008 |
Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression.
Topics: Anilides; Binding Sites; Cells, Cultured; Gene Expression Regulation; Humans; Liver; Mutant Proteins; PPAR alpha; PPAR delta; PPAR gamma; Promoter Regions, Genetic; Rosiglitazone; Sex Hormone-Binding Globulin; Thiazolidinediones; Tretinoin | 2009 |
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Anilides; Animals; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Caspase 3; Caspase 9; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Glucose; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neuroblastoma; Phosphorylation; Poly(ADP-ribose) Polymerases; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection; Up-Regulation | 2009 |
Anti-inflammatory effect of peroxisome proliferator activated receptor gamma on human dental pulp cells.
Topics: Anilides; Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Dental Pulp; Escherichia coli; Fibroblasts; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; PPAR gamma; Pulpitis; Recombinant Proteins; Rosiglitazone; Thiazolidinediones; Vascular Cell Adhesion Molecule-1 | 2009 |
Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
Topics: Adenocarcinoma; Anilides; Bronchi; Calcium Signaling; Cell Division; Cell Line, Transformed; Cell Line, Tumor; Chromans; Humans; Hypoglycemic Agents; Lung Neoplasms; PPAR gamma; Receptors, G-Protein-Coupled; Respiratory Mucosa; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Troglitazone | 2009 |
Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Tubules; Losartan; Male; Mesangial Cells; NF-kappa B; PPAR gamma; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2009 |
Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.
Topics: Adipocytes; Amino Acid Motifs; Angiotensin-Converting Enzyme Inhibitors; Anilides; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Cell Line; Humans; Hypoglycemic Agents; Ligands; Mutation; Nuclear Proteins; Peptides; PPAR gamma; Protein Array Analysis; Recombinant Fusion Proteins; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factors | 2009 |
Peroxisome proliferator-activated receptor gamma activation alleviates postoperative ileus in mice by inhibition of Egr-1 expression and its downstream target genes.
Topics: Anilides; Animals; Blotting, Western; Colon; Cyclooxygenase 2; DNA; Down-Regulation; Early Growth Response Protein 1; Enzyme-Linked Immunosorbent Assay; Gastrointestinal Motility; Gene Expression; Heme Oxygenase-1; Ileus; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Postoperative Complications; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
Topics: Anilides; Animals; Cell Line; Gene Expression Regulation; Genes, Reporter; Humans; Hypoglycemic Agents; PPAR gamma; Receptors, G-Protein-Coupled; Receptors, Peptide; Relaxin; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Swine; Thiazolidinediones | 2010 |
Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests.
Topics: Anilides; Animals; Antidepressive Agents; Corticosterone; Depressive Disorder; Disease Models, Animal; Drug Evaluation, Preclinical; Immobility Response, Tonic; Male; Mice; Motor Activity; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Swimming; Thiazolidinediones | 2009 |
Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
Topics: Anilides; Animals; Benzamides; Biological Transport; Cell Survival; CHO Cells; Chromans; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Hypoglycemic Agents; Insulin; Membrane Potentials; Pioglitazone; PPAR gamma; Pyridines; Rosiglitazone; Sodium; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone | 2009 |
Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Topics: Anilides; Berberine; Blotting, Western; Carnitine O-Palmitoyltransferase; CD36 Antigens; Cell Line; Cell Survival; Fatty Acids; Fatty Acids, Nonesterified; Gene Expression; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Muscle Fibers, Skeletal; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion.
Topics: Anilides; Animals; Antioxidants; Cell Nucleus; Cerebral Cortex; Cytosol; Disease Models, Animal; Flavanones; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Male; PPAR gamma; Protein Transport; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Time Factors; Up-Regulation | 2010 |
Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.
Topics: Anilides; Animals; Benzhydryl Compounds; Brain; Central Nervous System Agents; Disease Models, Animal; Edema; Epoxy Compounds; Gene Expression; Inflammation; Male; Pain; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spinal Cord; Thiazolidinediones | 2010 |
Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
Topics: Adipocytes; Adult; Anilides; Cell Differentiation; Cell Line; Cells, Cultured; Female; Gene Expression; Humans; Obesity; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2010 |
Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo.
Topics: Anilides; Animals; Animals, Newborn; Gene Expression Regulation; Gene Knockdown Techniques; Glucose Transporter Type 4; Hypothalamus; Injections, Intraventricular; Mice; Pioglitazone; PPAR gamma; Promoter Regions, Genetic; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones; Thyroid Hormone Receptors beta; Thyrotropin-Releasing Hormone; Thyroxine; Transfection; Triiodothyronine | 2010 |
Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 macrophages and mouse bone marrow cells through downregulation of NFATc1.
Topics: Anilides; Animals; Bone Marrow Cells; Cell Differentiation; Cell Line; Down-Regulation; Macrophages; Mice; NFATC Transcription Factors; Osteoclasts; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2010 |
The novel function of nesfatin-1: anti-hyperglycemia.
Topics: Anilides; Animals; Appetite Depressants; Blood Glucose; Calcium-Binding Proteins; DNA-Binding Proteins; Eating; Hyperglycemia; Hypolipidemic Agents; Insulin; Mice; Mice, Mutant Strains; Nerve Tissue Proteins; Nucleobindins; Peptide Hormones; Pyrazoles; Pyrimidines; Receptors, Leptin; Rosiglitazone; Thiazolidinediones | 2010 |
Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells.
Topics: Adult; Anilides; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Granulosa Cells; Humans; Interleukin-6; Luteal Cells; PPAR gamma; Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rosiglitazone; Steroids; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Topics: Angiogenesis Inhibitors; Anilides; Benzhydryl Compounds; Benzophenones; Binding Sites; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endothelial Cells; Epoxy Compounds; Gene Expression Regulation, Enzymologic; Humans; Neovascularization, Physiologic; Nitrobenzenes; PPAR gamma; Promoter Regions, Genetic; Protein Kinase C-alpha; Protein Transport; RNA Interference; RNA, Messenger; Rosiglitazone; Sulfonamides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transfection; Tyrosine; Vascular Endothelial Growth Factor A | 2010 |
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
Topics: Adaptor Proteins, Signal Transducing; Anilides; Animals; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Immunoblotting; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet Membrane Glycoproteins; PPAR gamma; Prostaglandin D2; Protein-Tyrosine Kinases; Rosiglitazone; Signal Transduction; Spectrometry, Fluorescence; Syk Kinase; Thiazolidinediones; Thrombosis; Time Factors; Tyrosine | 2010 |
Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Topics: Anilides; Animals; Cells, Cultured; Culture Media, Conditioned; Down-Regulation; Inflammation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxyhemoglobins; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vasodilator Agents; Vasospasm, Intracranial | 2010 |
Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Topics: Anilides; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Northern; Blotting, Western; Caspase 3; Cell Line; Cell Survival; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Mice; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Myocardial Reperfusion Injury; Myocardium; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Phosphorylation; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection | 2010 |
Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.
Topics: Anilides; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Humans; Mucin-1; Phosphorylation; PPAR alpha; PPAR gamma; Progesterone; Promoter Regions, Genetic; Protein Binding; Receptors, Progesterone; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2010 |
Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anilides; Anti-Inflammatory Agents; Antimetabolites; Asthma; Cells, Cultured; Chromans; Cytokines; Enzyme Activators; Enzyme Inhibitors; Gene Knockdown Techniques; Humans; Hypoglycemic Agents; Inflammation Mediators; Metformin; Myocytes, Smooth Muscle; PPAR gamma; Pyrazoles; Pyrimidines; Respiratory System; Ribonucleotides; Rosiglitazone; Thiazolidinediones; Troglitazone; Vidarabine | 2011 |
Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
Topics: Adenoviridae; Anilides; Animals; beta-Galactosidase; Choline; Diet; Fatty Liver; Genetic Vectors; Inflammation; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Methionine; Mice; Mice, Inbred C57BL; PPAR gamma; Random Allocation; Rosiglitazone; Thiazolidinediones; Transfection | 2011 |
Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles.
Topics: Anilides; Bronchi; Calcimycin; Cell Line; Cell-Derived Microparticles; Cells, Cultured; Chemokine CCL2; Humans; Interleukin-8; Ionophores; Monocytes; NF-kappa B; Pneumonia; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2011 |
Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells.
Topics: Anilides; Animals; Antioxidants; Blotting, Western; Catalase; Cats; Cell Culture Techniques; Cell Survival; Cells, Cultured; Culture Media; Epithelial Cells; Esophagus; Female; Hydrochloric Acid; Hydrogen Peroxide; Hydrogen-Ion Concentration; Male; NADP; PPAR gamma; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2011 |
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol Drinking; Alcohols; Analysis of Variance; Anilides; Animals; Behavior, Animal; Blood Glucose; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Food Preferences; Gene Expression Regulation; Hypoglycemic Agents; Male; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Self Administration; Substance Withdrawal Syndrome; Thiazolidinediones; Yohimbine | 2011 |
[PPARγ up-regulates TGFβ/smad signal pathway repressor c-Ski].
Topics: Anilides; Animals; Atherosclerosis; Cells, Cultured; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Proto-Oncogene Proteins; Rats; Rats, Wistar; Repressor Proteins; RNA, Messenger; Rosiglitazone; Signal Transduction; Smad Proteins; Thiazolidinediones; Transforming Growth Factor beta; Up-Regulation | 2011 |
The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes.
Topics: 3T3 Cells; Adipogenesis; Anilides; Animals; Environmental Pollutants; Gene Expression; Mice; PPAR gamma; Rosiglitazone; Thiazolidinediones; Trialkyltin Compounds; Triglycerides | 2011 |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Topics: Anilides; Animals; Arachidonic Acids; Benzodioxoles; Biphenyl Compounds; Cannabinoid Receptor Modulators; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Excitatory Postsynaptic Potentials; Glycerides; Hippocampus; Inflammation; Interleukin-1beta; Lipopolysaccharides; Mice; Monoacylglycerol Lipases; Neurons; NF-kappa B; Phosphorylation; Piperidines; PPAR gamma; Prostaglandin D2; Receptor, Cannabinoid, CB1; Rosiglitazone; Signal Transduction; Synaptic Transmission; Thiazolidinediones | 2011 |
Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
Topics: AMP-Activated Protein Kinases; Anilides; Animals; Cardiotonic Agents; Disease Models, Animal; Drug Administration Schedule; Enzyme Activation; Injections, Intravenous; JNK Mitogen-Activated Protein Kinases; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; PPAR gamma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Rosiglitazone; Signal Transduction; Thiazolidinediones; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells.
Topics: Anilides; Animals; Blood Urea Nitrogen; Chemokine CCL2; Creatinine; Humans; Hypoglycemic Agents; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; Mice; NF-kappa B; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Trans-10, cis-12 conjugated linoleic acid and the PPAR-γ agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-α production by bovine immune cells.
Topics: Anilides; Animals; Cattle; Cell Proliferation; Cells, Cultured; Female; Gene Expression Regulation; Hypoglycemic Agents; Interferon-gamma; Leukocytes, Mononuclear; Linoleic Acids, Conjugated; Lipopolysaccharides; NF-kappa B; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2011 |
Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Topics: Anilides; Antineoplastic Agents; Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Lymphoma; Phosphorylation; PPAR gamma; Rosiglitazone; Thiazolidinediones; Wnt Signaling Pathway | 2012 |
Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.
Topics: Anilides; Aorta; Cells, Cultured; Humans; Lipid Metabolism; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Plaque, Atherosclerotic; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2011 |
The influence of peroxisome proliferator-activated receptor γ(1) during differentiation of mouse embryonic stem cells to neural cells.
Topics: Anilides; Animals; Astrocytes; Cell Differentiation; Embryonic Stem Cells; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurogenesis; Neurons; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tretinoin | 2012 |
Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
Topics: Anilides; Animals; Blotting, Western; Cell Line; Cells, Cultured; Glucose; Huntington Disease; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mice; Polymerase Chain Reaction; PPAR gamma; Pyruvic Acid; Rats; Reactive Oxygen Species; Rolipram; Rosiglitazone; Superoxides; Thapsigargin; Thiazolidinediones | 2012 |
Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
Topics: Anilides; Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2012 |
Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.
Topics: Anilides; Apoptosis; Caco-2 Cells; cdc42 GTP-Binding Protein; Cell Growth Processes; Colorectal Neoplasms; HCT116 Cells; Humans; Ligands; Madin Darby Canine Kidney Cells; Molecular Targeted Therapy; PPAR gamma; PTEN Phosphohydrolase; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection | 2013 |
Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase.
Topics: Age Factors; Anilides; Animals; Animals, Newborn; Cardiotonic Agents; Catalase; Heart; Hydrogen Peroxide; L-Lactate Dehydrogenase; Organ Culture Techniques; Oxidative Stress; Pioglitazone; PPAR gamma; Rabbits; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Up-Regulation; Ventricular Function, Left | 2012 |
Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.
Topics: Anilides; Animals; Chromans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Femoral Artery; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Troglitazone; Vasoconstriction | 2013 |
β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.
Topics: Adipocytes; Anilides; Animals; beta Catenin; Bone Marrow Cells; Cell Differentiation; Cell Line; Gene Expression Regulation; Gene Silencing; Insulin; Lithium Chloride; Mesenchymal Stem Cells; Mice; Mutation; Osteoblasts; PPAR gamma; Protein Stability; Proteolysis; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Topics: Anilides; Animals; Biomarkers; Calcinosis; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Ligands; Male; Muscle, Smooth, Vascular; Osteoblasts; Phenotype; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Troglitazone; Vasoconstriction | 2013 |
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.
Topics: Adenosine Triphosphate; Anilides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Disease Models, Animal; Gene Expression Regulation; Glutamates; Humans; Huntingtin Protein; Huntington Disease; Hyperglycemia; Intracellular Signaling Peptides and Proteins; L-Lactate Dehydrogenase; Male; Mice; Mice, Transgenic; Movement Disorders; Nerve Tissue Proteins; Neurons; Neuropeptides; Neuroprotective Agents; Orexins; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; RNA, Messenger; Rosiglitazone; Sirtuins; Thiazolidinediones; Trans-Activators; Transcription Factors; Transfection; Trinucleotide Repeat Expansion | 2013 |
Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Topics: Adult; Aged; Amino Acid Sequence; Angiotensin II; Anilides; Animals; Case-Control Studies; Enzyme Activation; Female; Fibroblasts; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hypertension; Inflammation Mediators; Leukocytes, Mononuclear; Lipodystrophy, Familial Partial; Male; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Oxidative Stress; Phenotype; PPAR gamma; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA Interference; Rosiglitazone; Severity of Illness Index; Skin; Thiazolidinediones; Transfection; Young Adult | 2013 |
Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Topics: Amyloid beta-Peptides; Anilides; Animals; Cells, Cultured; Central Nervous System Agents; Dendrites; Dendritic Spines; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mitochondria; Neuronal Plasticity; Neurons; Nootropic Agents; Peptide Fragments; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Synapses; Thiazolidinediones; Time Factors | 2014 |
The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2α production by porcine endometrium.
Topics: Analysis of Variance; Anilides; Animals; Benzamides; Culture Media; Dinoprost; DNA Primers; Endometrium; Estrous Cycle; Female; Indoles; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Pregnancy; Prostaglandin D2; Pyridines; Pyrimidines; Radioimmunoassay; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Swine; Thiazolidinediones | 2013 |
Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.
Topics: Anilides; Animals; Cardiotoxins; Dose-Response Relationship, Drug; Energy Metabolism; Heart; Heart Function Tests; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Oxidative Stress; Perfusion; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2014 |
Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.
Topics: alpha-2-HS-Glycoprotein; Anilides; Animals; Cell Line, Tumor; Diabetes Mellitus, Type 2; Gene Expression; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Mice; Mice, Inbred C57BL; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2014 |
PPARγ recruitment to active ERK during memory consolidation is required for Alzheimer's disease-related cognitive enhancement.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anilides; Animals; Cognition; Female; Hippocampus; Humans; Injections, Intraventricular; Male; MAP Kinase Signaling System; Memory; Mice; Mice, Inbred Strains; Mice, Transgenic; Middle Aged; Nootropic Agents; Phosphorylation; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2014 |
Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.
Topics: Anilides; Animals; Arachidonic Acids; Camphanes; Cell Line; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dehydroepiandrosterone; Dinoprostone; Endocannabinoids; Indenes; Interferon-beta; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; NF-kappa B; Nitric Oxide; Piperidines; PPAR gamma; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Rosiglitazone; Thiazolidinediones; Toll-Like Receptor 3; Toll-Like Receptor 4 | 2015 |
Coordinate regulation between the nuclear receptor peroxisome proliferator-activated receptor-γ and cyclooxygenase-2 in renal epithelial cells.
Topics: Anilides; Animals; Base Sequence; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; DNA Primers; Dogs; Epithelial Cells; Kidney; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinases; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sodium Chloride; Thiazolidinediones | 2014 |
A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.
Topics: Anilides; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; PPAR gamma; Resveratrol; Rosiglitazone; S Phase Cell Cycle Checkpoints; Stilbenes; Thiazolidinediones | 2014 |
In vitro interaction between resistin and peroxisome proliferator-activated receptor γ in porcine ovarian follicles.
Topics: Age Factors; Anilides; Animals; Cells, Cultured; Estradiol; Female; Follicular Fluid; Gene Expression Regulation, Developmental; Ovarian Follicle; PPAR alpha; PPAR gamma; PPAR-beta; Progesterone; Resistin; RNA, Messenger; Rosiglitazone; Sexual Maturation; Swine; Thiazolidinediones | 2016 |
Rosiglitazone inhibits hepatic insulin resistance induced by chronic pancreatitis and IKK-β/NF-κB expression in liver.
Topics: Anilides; Animals; Drug Evaluation, Preclinical; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Hepatocytes; I-kappa B Kinase; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Pancreatitis, Chronic; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA | 2014 |
PPARγ ablation sensitizes proopiomelanocortin neurons to leptin during high-fat feeding.
Topics: Anilides; Animals; Diet, High-Fat; Energy Metabolism; Female; Glucose; Hyperphagia; Insulin Resistance; Leptin; Male; Mice; Motor Activity; Neurons; PPAR gamma; Pro-Opiomelanocortin; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones | 2014 |
Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy.
Topics: 3-Hydroxysteroid Dehydrogenases; Anilides; Animals; Benzamides; Corpus Luteum; Estradiol; Estrous Cycle; Female; Gene Expression; Indoles; Ligands; Peroxisome Proliferator-Activated Receptors; Phenoxyacetates; Pregnancy; Progesterone; Prostaglandin D2; Pyridines; Pyrimidines; RNA, Messenger; Rosiglitazone; Swine; Thiazolidinediones | 2014 |
Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Topics: Anilides; Animals; Apoptosis; Cell Line; Cell Survival; Enzyme Inhibitors; Hypoglycemic Agents; Insulin Resistance; Mice; Myoblasts, Skeletal; Palmitates; PPAR gamma; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rosiglitazone; Thiazolidinediones | 2014 |
Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.
Topics: Adipocytes; Adipogenesis; Anilides; Animals; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cricetinae; Dexamethasone; Dogs; Humans; In Vitro Techniques; Mesenchymal Stem Cells; Mesocricetus; Mice; Mice, Inbred C57BL; Mifepristone; PPAR gamma; Rabbits; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2015 |
Identification and characterisation of a prototype for a new class of competitive PPARγ antagonists.
Topics: Anilides; Cell Line; Cell Survival; Cinnamates; Humans; Luciferases; Molecular Docking Simulation; PPAR gamma; Quinolines; Rosiglitazone; Thiazolidinediones; Transcriptional Activation | 2015 |
Damage to vascular endothelial cells by high insulin levels is associated with increased expression of ChemR23, and attenuated by PPAR-gamma agonist, rosiglitazone.
Topics: Anilides; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; Insulin; PPAR gamma; Receptors, Chemokine; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Anilides; Animals; Blood Pressure; Body Weight; Cell Proliferation; Cells, Cultured; Cyclin D1; Gene Expression Regulation; Hypoglycemic Agents; Kruppel-Like Transcription Factors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; PPAR gamma; Prostaglandin D2; Protein Kinase C; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2015 |
Cardiac differentiation of mouse embryonic stem cells is influenced by a PPAR γ/PGC-1α-FNDC5 pathway during the stage of cardiac precursor cell formation.
Topics: Anilides; Animals; Ascorbic Acid; Biomarkers; Cell Differentiation; Down-Regulation; Fibronectins; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Mitochondria; Mouse Embryonic Stem Cells; Myocardium; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Up-Regulation | 2015 |
[The role of peroxisome proliferator-activated receptor-γ/nuclear factor-ΚB transduction pathway on coagulation disorders induced by sepsis].
Topics: Anilides; Animals; Blood Coagulation; Blood Coagulation Tests; Fibrin Fibrinogen Degradation Products; Leukocytes, Mononuclear; Lipopolysaccharides; Male; NF-kappa B; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Signal Transduction; Thiazolidinediones | 2015 |
Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes.
Topics: Active Transport, Cell Nucleus; Anilides; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta Catenin; Cell Line, Tumor; Cell Nucleus; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Frizzled Receptors; Humans; Ovarian Neoplasms; Paclitaxel; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription, Genetic; Wnt Proteins | 2015 |
[Effects of proliferator-activated receptor-γ agonist on vascular endothelial injuries in septic rats].
Topics: Angiopoietin-2; Anilides; Animals; Endothelium, Vascular; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Thiazolidinediones; Thromboplastin; Vascular Cell Adhesion Molecule-1 | 2015 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Cattle; Cell Adhesion; Diabetes Mellitus; Endothelial Cells; Humans; Hyperglycemia; I-kappa B Kinase; Inflammation; Monocytes; PPAR gamma; Rosiglitazone; Telmisartan; Thiazolidinediones; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
A PPARγ AGONIST ENHANCES BACTERIAL CLEARANCE THROUGH NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND IMPROVES SURVIVAL IN SEPSIS.
Topics: Anilides; Animals; Disease Models, Animal; Escherichia coli; Extracellular Traps; Male; Mice; Neutrophils; PPAR gamma; Rosiglitazone; Sepsis; Signal Transduction; Thiazolidinediones | 2016 |
Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
Topics: Action Potentials; Anilides; Animals; CA1 Region, Hippocampal; Culture Media; Epilepsy, Temporal Lobe; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Glutamic Acid; Magnesium; Microtomy; Models, Biological; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Seizures; Synaptic Transmission; Thiazolidinediones; Tissue Culture Techniques | 2015 |
PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.
Topics: Anilides; Breast Neoplasms; CA-125 Antigen; Female; Gene Expression Regulation, Neoplastic; Humans; Interferon-gamma; MCF-7 Cells; Membrane Proteins; Neoplasm Proteins; Ovarian Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2017 |
PPAR-γ activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction.
Topics: Anilides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus Shape; Dopaminergic Neurons; Electron Transport Complex I; Gene Expression Regulation, Enzymologic; Humans; Hypoglycemic Agents; Insecticides; Membrane Potential, Mitochondrial; Mitochondria; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitriles; PPAR gamma; Protein Kinases; Protein Transport; Pyrethrins; RNA Interference; Rosiglitazone; Thiazolidinediones | 2016 |
Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells.
Topics: Acyltransferases; Anilides; Animals; Blotting, Northern; Caco-2 Cells; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Computational Biology; HT29 Cells; Humans; Kidney Tubules, Proximal; Liver; Mice; Oxazoles; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; Rats; Real-Time Polymerase Chain Reaction; Rosiglitazone; Sulfones; Thiazoles; Thiazolidinediones; Thiophenes; Tyrosine | 2016 |
Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARγ in isolated beating rat atria.
Topics: Angiotensin II; Anilides; Animals; Blotting, Western; Connexin 43; Connexins; Dose-Response Relationship, Drug; Down-Regulation; Female; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; Heart Atria; Male; Matrix Metalloproteinase 2; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.
Topics: Alanine Transaminase; Anilides; Animals; Apoptosis; Aspartate Aminotransferases; Cell Polarity; Cytokines; Disease Models, Animal; Kupffer Cells; Lectins, C-Type; Liver; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Necrosis; Nitric Oxide; PPAR gamma; Receptors, Cell Surface; Reperfusion Injury; Rosiglitazone; Thiazolidinediones | 2018 |
Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways.
Topics: Anilides; Animals; Cell Proliferation; Down-Regulation; Female; Hepatectomy; Hepatocyte Growth Factor; Hepatocytes; Liver; Liver Regeneration; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-met; Pyridazines; Rosiglitazone; Signal Transduction; Triazoles | 2018 |
Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Intracranial Hemorrhages; Lectins, C-Type; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Plasminogen Activators; PPAR gamma; Receptors, Cell Surface; Rosiglitazone; Stroke; Tissue Plasminogen Activator | 2019 |
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.
Topics: Anilides; Benzamides; Binding Sites; Co-Repressor Proteins; Hydrogen Deuterium Exchange-Mass Spectrometry; Ligands; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Peptides; PPAR gamma; Protein Conformation, alpha-Helical; Pyridines; Rosiglitazone | 2019 |
Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPARγ expression.
Topics: Anilides; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice, SCID; Neoplasms, Experimental; PPAR gamma; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Peroxisome Proliferator-Activated Receptor Gamma Modulator Promotes Neonatal Mouse Primordial Follicle Activation In Vitro.
Topics: Anilides; Animals; Animals, Newborn; Cells, Cultured; Female; Forkhead Box Protein O3; Gene Expression Regulation, Developmental; In Vitro Techniques; Mice; Ovarian Follicle; Phosphatidic Acids; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rosiglitazone; Signal Transduction | 2020 |
Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Topics: Anilides; Animals; Benzamides; Butadienes; Carrier Proteins; Cells, Cultured; Cytokines; Dinoprostone; Female; Gene Expression Regulation; Nitriles; Phenoxyacetates; PPAR delta; PPAR gamma; PPAR-beta; Pregnancy; Rosiglitazone; Sulfones; Swine; Trophoblasts | 2020 |
The protective effect of PPARγ in sepsis-induced acute lung injury via inhibiting PTEN/β-catenin pathway.
Topics: Acute Lung Injury; Anilides; Animals; Apoptosis; beta Catenin; Disease Models, Animal; Lung; Male; Phosphorylation; Pneumonia; PPAR gamma; PTEN Phosphohydrolase; Pulmonary Edema; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Signal Transduction | 2020 |
Expression of TNF‑α and IL‑β can be suppressed via the PPAR‑γ/mTOR signaling pathway in BV‑2 microglia: A potential anti‑inflammation mechanism.
Topics: Anilides; Animals; Cell Line; Gene Expression Regulation; Interleukin-1beta; Lipopolysaccharides; Mice; Microglia; Phosphatidic Acids; Phosphorylation; PPAR gamma; Rosiglitazone; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2020 |
Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Astrocytes; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fenofibrate; Interleukin-10; Lipopolysaccharides; MAP Kinase Kinase 4; Oxazoles; Oxylipins; p38 Mitogen-Activated Protein Kinases; PPAR gamma; PPAR-beta; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Tumor Necrosis Factor-alpha; Tyrosine | 2020 |
PPARγ activation suppresses the expression of MMP9 by downregulating NF-κB post intracerebral hemorrhage.
Topics: Anilides; Animals; Cell Line; Cerebral Hemorrhage; Disease Models, Animal; Down-Regulation; Humans; Male; Matrix Metalloproteinase 9; Mice; NF-kappa B; Phenylenediamines; PPAR gamma; Rats; Rosiglitazone | 2021 |
Molecular mechanism of benign biliary stricture inhibition by rosiglitazone-activated peroxisome proliferator-activated receptor gamma.
Topics: Animals; Collagen Type I; Connective Tissue Growth Factor; Constriction, Pathologic; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Transforming Growth Factors | 2022 |
PPARγ/RAD21 alleviates peripheral secondary brain injury in rat cerebral hemorrhage model through promoting M2 polarization of microglial cells.
Topics: Animals; Brain Injuries; Brain Neoplasms; Cerebral Hemorrhage; Interleukin-10; Microglia; PPAR gamma; Rats; Rosiglitazone; Thrombin; Tumor Necrosis Factor-alpha | 2023 |